Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Equity Average (2016 - 2025)

Historic Equity Average for Surgery Partners (SGRY) over the last 11 years, with Q3 2025 value amounting to $3.1 billion.

  • Surgery Partners' Equity Average rose 16.38% to $3.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 16.38%. This contributed to the annual value of $3.1 billion for FY2024, which is 427.59% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Equity Average is $3.1 billion, which was up 16.38% from $3.2 billion recorded in Q2 2025.
  • Surgery Partners' 5-year Equity Average high stood at $3.2 billion for Q1 2025, and its period low was $993.7 million during Q1 2021.
  • Moreover, its 5-year median value for Equity Average was $3.0 billion (2023), whereas its average is $2.5 billion.
  • As far as peak fluctuations go, Surgery Partners' Equity Average skyrocketed by 10925.78% in 2021, and later grew by 16.38% in 2025.
  • Quarter analysis of 5 years shows Surgery Partners' Equity Average stood at $1.8 billion in 2021, then soared by 43.3% to $2.5 billion in 2022, then grew by 19.32% to $3.0 billion in 2023, then increased by 4.77% to $3.2 billion in 2024, then decreased by 0.16% to $3.1 billion in 2025.
  • Its last three reported values are $3.1 billion in Q3 2025, $3.2 billion for Q2 2025, and $3.2 billion during Q1 2025.